TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Bilateral Calf Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes to glycan structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glycoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AAA Sac Regression at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Adverse Event (MAE) Rate through 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Canadian Occupational Performance measure (COPM-p)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in acceptability of MINISTOP 3.0
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in appropriateness of MINISTOP 3.0
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in feasibility of MINISTOP 3.0
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in organizational readiness for implementing MINISTOP 3.0
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Pediatric Participants with Clinical Remission at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence Rate of Acute Pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Preoperative and postoperative scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vulvovaginal Symptoms Questionnaire (VSQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Vulvar Disease Quality of Life Index (VQLI) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in resting mean heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ventilatory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Lower Limb Strength: 30 s Sit-to-Stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in walking speed: Brisk Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cardiovascular fitness: 6-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Rate the Intervention as Feasible
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Narcotic Pills Used
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tremor frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Power spectral analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Orthostatic Tremor Severity and Disability Scale (OT-10)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of clinical risk factors for colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of biological risk factors for colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency rate
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Response (CR)/Stringent Complete Response (sCR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of Very Good Partial Response (VGPR) or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete minimal residual disease (MRD) Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rates of women diagnosed with HMB per year
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rates of women diagnosed with HMB over the entire study period
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of women receiving a diagnosis of HMB over the entire study period
Endpoint domain: Mortality/survival
Primary endpoint: Pro-Beta Natriuretic Peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of hemodialysis session success without heparin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Venous ammonia level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Lung Ultrasound Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Enrollment rate of clinicians and caregivers combined
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of complete data collection by caregivers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Antiretroviral therapy (ART) drug pickup adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of CD41a+/CD45- platelet clusters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility of initiating the 'bundle of care'
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of delivering a single education package
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in percentiles on clinical assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days MDR-KP turns negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting-state functional connectivity (rsFC) of frontostriatal networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amount of innate immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Activation level of innate immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression level of cytokines and/or rNKG2D ligands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of prenatal maternal attachment level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment of prenatal paternal attachment level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment of spousal adjustment of pregnant women
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Papilla augmentation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortisol concentration in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: glucose concentration in capillary blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: stress index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rhythm index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cardiovascular mortality or first non-fatal ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Total rate of heart failure admissions or healthcare facility visits for IV diuresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) total summary score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Administration of extracellular vesicles (EVs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Injection site reactions assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-Drug Antibody(ADA)
Endpoint domain: Adverse events/effects
Primary endpoint: Improved MDS-UPDRS scale scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal polyps score (NPS) at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal congestion score (NCS) at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS for CRSwNP symptoms at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to guidelines for Chest Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to guidelines for CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to guidelines for Antibiotic prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visuospatial skills improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alexithymia modulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain activity investigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in unmet need for contraceptives at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in unmet need for contraceptives at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visualization of flow relative to the interspace insertion level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numerical scale of pain level 0-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder joint mobility according to FMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived child emotion regulation ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quality of skin suture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Instrumental Color assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual color assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corticospinal transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale- Cognition Subscale (ADAS-cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical dementia rating scale-sum box (CDR-SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Activity - Godin Leisure Time Exercise Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Activity - Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 - Physical Function 20a
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mucosal immunity response to SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tissue growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of FMT and gut-related microbiota products
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor-level CMS4 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Skeletal muscle tissue quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle tissue quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Body Muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Body Muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adhesion extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma control questionnaire-7 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical practice skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical decision making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neutrophil-lymphocyte ratio (NLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GVHD-free relapse-free survival (GRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Grade III-IV acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Six-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in percent predicted forced vital capacity (%FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Late physician-assessed morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Acute physician-assessed morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural time to 1L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and dyspnea scores- 24h post
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of multimodal prehabilitation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of multimodal prehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of multimodal prehabilitation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total Time to Complete the Time Up and Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission at end of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to CRRT discontinuation
Endpoint domain: Mortality/survival
Primary endpoint: preoperative nursing care competencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: students' anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fatigue Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: global inhomogeneity index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: forced expiratory volume in 1s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline global cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline quadriceps muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Association between psychological factors and H.Pylori associated gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Depression, Anxiety and Stress Scale - DASS-21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change scores of Timed up and go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change scores of Grip strength (GS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentages of CD8+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentages of NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in urine output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amplitude of the Reward Potential (RewP) in Microvolts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of the Late Positive Potential (LPP) in Microvolts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Acute Lumen Gain in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dwell Time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in surface electromyographic (EMG) amplitude of sternocleidomastoid muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spleen Volume Response rate (SVRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular End-systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to First Protocol-defined Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clinical decision rule usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Histological resolution of biopsy-proven acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in allograft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Avoidance of rescue therapies within 12 weeks post-randomisation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Content and face validity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mapping of Indonesian population's skin type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: uNTX/uCr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Critical Incident During Anaesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Anxiety as Measured by Visual Analog Scale (VAS-A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain, Enjoyment of Life and General Activity scale (PEG)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Milligrams of Morphine Equivalent (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readability or Interpretation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Label Comprehension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Peak torque at 60°/s knee extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neurodegeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in symptom control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Constant-Murley Shoulder Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in the severity of the depressive disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-operative pain level change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Revision rate of the femoral component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the concentration-time curve (AUC0-∞) of oral and intravenous primaquine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of primaquine and carboxyprimaquine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination clearance (CL/F) of primaquine and carboxyprimaquine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Performance on a Reality monitoring task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Performance on an externalization task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ketone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility measured by recruitment and retention rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of the visual field index as mean deviation (MD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of the visual field index as visual field index (VFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Signal Noise Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total inhaled volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF-5 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Early Feeding Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Time to Sustained Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Percentage of Participants With Overall Adverse Events, Related Adverse Reactions, and Hospitalizations
Endpoint domain: Adverse events/effects